Literature DB >> 3348650

Insulin dependent diabetes in thalassaemia.

V De Sanctis1, M G Zurlo, E Senesi, C Boffa, L Cavallo, F Di Gregorio.   

Abstract

Diabetes mellitus was observed in 29 of 448 patients with thalassaemia major attending seven Italian centres. Twelve patients, at onset of clinical diabetes, presented with an asymptomatic glycosuria, 13 with ketosis, and four with ketoacidosis. All were diagnosed after 1979, at a mean age of 17 years. Mean age at diagnosis of diabetes was lower in patients born in the last two decades. In these patients transfusions were started at a younger age and pre-transfusion haemoglobin concentration, serum ferritin concentration, incidence of liver disease, and the presence of a family history of diabetes were higher than in patients born previously. Although 27 (93%) cases had iron chelating treatment the mean serum ferritin concentration was 5600 micrograms/l; 25 (92%) of these patients had signs of liver impairment. The determination of C peptide in 10 patients showed a wide variation in pancreatic beta cell function, and insulin requirements ranged between 0.15 and 1.72 U/kg body weight. Metabolic control was generally poor. The onset of diabetes mellitus was followed in most patients by the appearance of other endocrine or cardiac complications, or both. Fourteen patients died within three years of presenting with overt diabetes. Haemosiderosis, liver infections, and genetic factors seemed to be crucial in diabetes development. Thalassaemic patients developing clinical diabetes mellitus are at high risk for other complications and should be strictly monitored, especially for thyroid impairment.

Entities:  

Mesh:

Year:  1988        PMID: 3348650      PMCID: PMC1779356          DOI: 10.1136/adc.63.1.58

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

1.  Endocrinopathy in thalassaemia major.

Authors:  N McIntosh
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

2.  Decreased vascular prostacyclin in juvenile-onset diabetes.

Authors:  K Silberbauer; G Schernthaner; H Sinzinger; H Piza-Katzer; M Winter
Journal:  N Engl J Med       Date:  1979-02-15       Impact factor: 91.245

3.  Carbohydrate homeostasis and pancreatic islet cell funtion in thalassemia.

Authors:  M N Lassman; M Genel; J K Wise; R Hendler; P Felig
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

4.  Diabetes mellitus and primary hypothyroidism.

Authors:  A Hecht; H Gershberg
Journal:  Metabolism       Date:  1968-02       Impact factor: 8.694

5.  Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.

Authors:  K Zuppinger; B Molinari; A Hirt; P Imbach; E Gugler; O Tönz; R P Zurbrügg
Journal:  Helv Paediatr Acta       Date:  1979

6.  Hormonal changes in thalassaemia major.

Authors:  D M Flynn; A Fairney; D Jackson; B E Clayton
Journal:  Arch Dis Child       Date:  1976-11       Impact factor: 3.791

7.  Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.

Authors:  G Costin; M D Kogut; C Hyman; J A Ortega
Journal:  Diabetes       Date:  1977-03       Impact factor: 9.461

8.  Red-cell aggregation and red-cell deformability in diabetes.

Authors:  H Schmid-Schönbein; E Volger
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

9.  Abnormal glucose tolerance in beta-thalassemia major.

Authors:  C D Saudek; R M Hemm; C M Peterson
Journal:  Metabolism       Date:  1977-01       Impact factor: 8.694

10.  The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients.

Authors:  V De Sanctis; G D'Ascola; B Wonke
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

View more
  13 in total

1.  Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets.

Authors:  Kim Cheng; Kenneth Ho; Rebecca Stokes; Christopher Scott; Sue Mei Lau; Wayne J Hawthorne; Philip J O'Connell; Thomas Loudovaris; Thomas W Kay; Rohit N Kulkarni; Terumasa Okada; Xiaohui L Wang; Sun Hee Yim; Yatrik Shah; Shane T Grey; Andrew V Biankin; James G Kench; D Ross Laybutt; Frank J Gonzalez; C Ronald Kahn; Jenny E Gunton
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 2.  Growth and endocrine function in thalassemia major in childhood and adolescence.

Authors:  M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

3.  A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk.

Authors:  David R Blair; Christopher S Lyttle; Jonathan M Mortensen; Charles F Bearden; Anders Boeck Jensen; Hossein Khiabanian; Rachel Melamed; Raul Rabadan; Elmer V Bernstam; Søren Brunak; Lars Juhl Jensen; Dan Nicolae; Nigam H Shah; Robert L Grossman; Nancy J Cox; Kevin P White; Andrey Rzhetsky
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

4.  Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy.

Authors:  Somchit Jaruratanasirikul; Rarong Chareonmuang; Malai Wongcharnchailert; Vichai Laosombat; Pasuree Sangsupavanich; Kalaya Leetanaporn
Journal:  Eur J Pediatr       Date:  2007-09-25       Impact factor: 3.183

5.  Pharmacokinetics of sex steroids in patients with beta thalassaemia major.

Authors:  M Katz; V De Sanctis; C Vullo; B Wonke; H H McGarrigle; B Bagni
Journal:  J Clin Pathol       Date:  1993-07       Impact factor: 3.411

6.  Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major.

Authors:  R G Grundy; K A Woods; M O Savage; J P Evans
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

7.  Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test.

Authors:  Holger Cario; Reinhard W Holl; Klaus-Michael Debatin; Elisabeth Kohne
Journal:  Eur J Pediatr       Date:  2003-01-15       Impact factor: 3.183

Review 8.  Iron overload in patients with myelodysplastic syndromes.

Authors:  Peter-D Jensen
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 4.213

9.  The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Saif Al Yaarubi; Nicos Skordis; Doaa Khater; Mohamed El Kholy; Iva Stoeva; Bernadette Fiscina; Michael Angastiniotis; Shahina Daar; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-28       Impact factor: 2.576

10.  Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study.

Authors:  Ashraf T Soliman; Mohamed Yasin; Ahmed El-Awwa; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.